Home Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer
 

Keywords :   


Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer

2016-01-23 03:23:46| Biotech - Topix.net

's stock had its "outperform" rating restated by equities research analysts at Oppenheimer in a research report issued to clients and investors on Friday, MarketBeat reports. They currently have a $4.00 price objective on the biotechnology company's stock.

Tags: rating receives gale outperform

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11How Japan's youngest CEO transformed Hello Kitty
31.10Unicharm to Expand in Africa
31.10Essity Named Diversity Leader by Financial Times
31.10Maxcess to Make FIFE Guiding Products in Mumbai
More »